3. Risk factors and diagnosis

Diagnosing glaucoma: Key factors during eye examinations

  • Patient risk factors: age, race, refractive error, systemic disease

  • Anterior chamber angle (ACA)

  • IOP (and central corneal thickness [CCT])

  • Optic nerve head (ONH) appearance

  • Retinal nerve fibre layer (RNFL)

  • Visual field (VF)

  • Interocular symmetry: IOP, ONH, VF

  • Changes over time

  • Marriage between ONH and VF (correlation of structure and function)

Glaucoma progression as a continuum

  • Glaucoma progression described as a continuum from asymptomatic to symptomatic, with detectable structural changes preceding functional loss and potential progression to blindness

  • Stages and relationships:

    • ASYMPTOMATIC DISEASE with detectable RNFL change

    • UNDETECTABLE DISEASE with neuronal apoptosis but undetectable RNFL change

    • Retinal nerve fiber layer change (undetectable) before VF changes

    • Short wavelength automated perimetry indicates VF changes before standard automated VF tests

    • Functional impairment progresses from detectable VF changes to moderate and severe VF loss

    • Final stage: Blindness

Epidemiological factors

  • Age:

    • POAG is age-related with increasing incidence after 60

  • Race:

    • Higher POAG prevalence in black Americans

    • Lower POAG prevalence in Asians (though higher prevalence of ACG in Asians)

  • Family history:

    • first-degree relatives confer markedly higher risk (up to 4–10× greater likelihood

    • 2× if a parent

    • 4× if a sibling

Systemic disease

  • Diabetes and systemic hypertension are important conditions to consider

  • Diabetics or hypertensives with untreated or uncontrolled glaucoma exhibit ONH damage sooner and faster

  • Glaucoma occurs more frequently in diabetics than in non-diabetics (possible ischemic contribution)

Other factors

  • Refractive status:

    • Myopia increases risk for POAG

    • Hyperopia increases risk for PACG

  • Medication use:

    • Topical steroids

    • Topical decongestants (slight risk of mydriasis and PACG in susceptible individuals)

  • History of eye trauma or surgery

  • Cataract surgery status: aphakia or pseudophakia

    • especially in young patients (congenital)

What raises suspicion?

  • Positive family history

  • Disc appearance:

    • cup-to-disc ratio (CD) ≥ 0.7

    • CD asymmetry ≥ 0.2

  • IOP characteristics:

    • raised IOP (> 22 mmHg)

    • IOP asymmetry > 5 mmHg

    • diurnal variation > 6 mmHg

  • Anterior chamber angle status: shallow angle (Van Herick grading)

  • Reduced central corneal thickness (CCT)

Clinical workup

  • Case history

  • Refraction and best corrected visual acuity

  • Optic nerve head appearance: stereoscopic view; photography for documentation over time

  • RNFL assessment: red-free filters (ophthalmoscopy, photography, OCT, etc.)

  • IOP assessment: serial/phase tensions (diurnal sampling if possible)

  • Computerised perimetry (threshold visual fields)

  • Pachymetry (CCT)

  • Anterior chamber/corneal assessment plus gonioscopy

  • Always correlate visual fields with disc and RNFL appearance

Intraocular pressure (IOP)

  • Mean IOP in adult population: 16±2.5 mmHg16 \, \pm \, 2.5\text{ mmHg}

  • Upper limit of “normal”: 21 mmHg21\text{ mmHg}

  • Many glaucoma patients have IOP < 21 mmHg

  • Framingham study: 33%50%33\%-50\% of glaucoma patients have IOP < 21 mmHg on a single reading

IOP – diurnal variations

  • IOP typically highest in the morning (around 6–7 AM) and lowest in the late evening (around 6–7 PM)

  • Average diurnal variation: 4 mmHg\approx 4\text{ mmHg}

  • Ocular hypertensives: diurnal variation around 78 mmHg7-8\text{ mmHg}

  • POAG: higher diurnal curve, range 1012 mmHg10-12\text{ mmHg}

  • Low-tension or normotensive glaucomas may also have IOP spikes

  • Suspicion if: IOP asymmetry > 5 mmHg5\text{ mmHg} or diurnal variation > 6 mmHg6\text{ mmHg}

  • Always note time of day and instrument used when measuring IOP

IOP and VF/ONH correlations (simplified)

  • IOP < 21 with Normal VF and Normal ONH

  • IOP > 21 with Normal VF and Normal ONH

  • IOP > 21 with Abnormal VF and Abnormal ONH

  • IOP < 21 with Abnormal VF and Abnormal ONH

Corrections for CCT and IOP

  • Thicker than average cornea = overestimate of IOP

  • Thinner than average cornea = underestimate of IOP

  • IOP correction factor for CCT: 0.5 mmHg per 10 µm

    • No correction factors have been validated

  • New tonometric techniques thought to give more accurate IOP reading closer to the true IOP (based on internal algorithms/design).

Central corneal thickness (CCT) and glaucoma

  • A thinner CCT is a risk factor for the development of glaucoma

  • In POAG: thinner CCT associated with larger CD ratio and more advanced visual field loss

  • Reasons for association:

    • Delayed diagnosis due to IOP underestimation with applanation tonometry in thin corneas

    • Potential intrinsic susceptibility: thinner CCT may reflect thinner lamina cribrosa (limited evidence)

Studies of “normal” healthy eyes (baseline references)

  • Framingham study: average CD ratio 0.25±0.170.25 \pm 0.17

  • Jonas (1988, n=475 normals): horizontal (H) 0.39±0.280.39 \pm 0.28; vertical (V) 0.34±0.250.34 \pm 0.25

  • Direct ophthalmoscopy: average CD ≈ 0.20.2

  • Stereoscopic view: average CD ≈ 0.40.4

  • Prevalence in normal populations:

    • 86% have CD ratio < 0.4

    • 7% have CD ratios ≥ 0.5

    • CD asymmetry > 0.2 present in only ~6% of normals

  • Conclusion: “Normal” ONH definitions rely on cup-to-disc metrics and symmetry thresholds

When to get suspicious?

  • General rule: CD ≥ 0.70.7 or CD asymmetry ≥ 0.20.2 warrants closer evaluation

  • A funny-looking disc or asymmetric CD/disc appearance warrants VF, OCT, and IOP monitoring

Pathological optic nerve head changes

  • Evidence of neural rim thinning and cell loss

  • Cupping patterns:

    • Concentric enlargement: cup enlarges in all directions

    • Focal enlargement (polar notch): cup elongated vertically compared to disc; inferior-temporal notching (avocado sign)

    • Laminar dot sign: lamina cribrosa becomes spotty and visible

    • Bean pot cup: end-stage with deep excavation and almost no neural rim left

Progression of glaucomatous cupping (illustrative sequence)

  • Focal enlargement (polar notch): cup is more vertically elongated than the disc, infero-temporal notching (avocado sign)

ISNT rule and neural rim tissue configuration

  • ISNT: Inferior – Superior – Nasal – Temporal

  • In glaucoma, rim tissue is often lost from inferior or superior poles

  • Result: nasal or temporal rims appear thicker than inferior or superior rims

  • Some healthy eyes do not follow ISNT; some glaucoma eyes do follow ISNT

End stage cupping

  • Cupped-out optic nerve head appearance in advanced disease

Pathological optic nerve head changes – vascular aspects

  • Disc pallor: neural rim tissue appears greyish; reduced capillaries

  • Baring of circumlinear vessels: vessels follow cup edge and are left behind as the cup enlarges

  • Splinter/Drance/Flame haemorrhages: within or at 1 disc diameter (1 DD) of the disc; common near the disc

  • Peripapillary atrophy: halo of pale retina around disc; RPE atrophy due to vascular deficiency

Optic disc haemorrhage (Drance/splinter haemorrhage)

  • Small flame-shaped haemorrhage, usually superficial NFL

  • Located on or adjacent to the disc (within 1 DD); most commonly inferotemporally

  • Resolves in 1–3 months; recurrences are common

  • More frequent in normotensives than in high-tension glaucoma

  • Indicator of early or progressive nerve damage, especially if recurrent

  • May precede ONH or VF defects

  • Easily missed; a deliberate search improves detection

  • Glaucoma patients with Drance haemorrhage are ~4× more likely to have VF progression than those without

Peripapillary atrophy and zones

  • Peripapillary atrophy: halo of pale retina surrounding disc; RPE atrophy due to vascular deficiency

  • Beta zone atrophy: RPE loss with choriocapillaris loss (more common in glaucoma)

  • Alpha zone atrophy: pigmentation changes (more common in normal eyes)

Visual fields in glaucoma

  • Within normal limits vs. severe glaucomatous loss

  • Disc appearance married to visual field defect: structure–function relationship

Glaucomatous defects (types and testing)

  • Earliest defects: generalized depression and nerve fibre bundle defects

  • Paracentral island scotomas: small, isolated, 5–15° from fixation; higher incidence in the superior field

    • Relative (reduction in sensitivity) or absolute (total loss of sensitivity) scotomas along the course of the arcuate nerve fibre path

  • Arcuate scotoma (Bjerrum scotoma): islands scotomas enlarge/coalesce along nerve fibre paths

    • respects the horizontal midline

  • Nasal step: sensitivity difference across horizontal raphe; may be central or peripheral; often with island scotomas

    • may take form of a depression or scotoma

    • may occur in isolation

  • Visual field testing in glaucoma (automated perimetry): designed to detect these defects; consider the Glaucoma Hemifield Test (GHT)

    • Emphasis on respect of horizontal midline; focal arcuate patterns are common

Paracentral island scotomas

  • Located along arcuate fibre paths; 5–15° from fixation

  • Predominantly found in the superior field in studies

Arcuate scotoma (Bjerrum pattern)

  • Island scotomas may enlarge and coalesce into an arcuate pattern following the fibre pathways

Nasal step

  • A sensitivity difference across the horizontal raphe; can appear as a depression or scotoma

  • May occur within central isopters (about 30°) or more peripherally

  • Often associated with island scotomas

Consider 10-2 VF in early and late stage; Central 24-2 Threshold Test

Mimic glaucoma VF loss (different etiologies that can resemble glaucoma VF loss)

  • Arcuate NFL bundle loss can be mimicked by:

    • Optic disc pit

    • Optic nerve head drusen

    • Optic nerve coloboma

    • Branch retinal vascular occlusions

Normal vs damaged optic nerve head (DIFFERENTIATORS)

  • ONH coloboma example: structural anomaly that can affect interpretation of RNFL and VF

Retinal nerve fibre layer defects (RNFL)

  • RNFL defects are among the earliest signs of glaucomatous damage in POAG

  • RNFL loss can precede VF loss and ONH damage

  • Normal RNFL appearance features:

    • fine white striations in the anterior retina

    • white haze over underlying areas

    • brighter closer to the ONH

RNFL thickness maps and deviation maps

  • RNFL Thickness Map and RNFL Thickness Deviation maps are used to visualize thinning relative to normative data

Detecting glaucoma before development of VF defect

  • 35% of eyes had abnormal average RNFL thickness 4 years before development of visual field loss

  • 19% of eyes had abnormal results 8 years before field loss

Clinical take-home messages

  • Evaluate ONH cupping and search for neural tissue loss and disc haemorrhages

  • Always search for RNFL defects in patients suspected of having glaucoma

  • Use dilated, stereoscopic observation for a thorough ONH assessment

  • Measure IOP in everyone (when possible)

  • Maintain a high degree of suspicion: symmetry of IOP, discs, and VF between eyes

RANZCO pathway for glaucoma management

Initial diagnosis and risk classification (RANZCO framework)

  • Early disc abnormality with some VF MD < 6 dB indicates Early glaucoma risk

  • Moderate glaucoma: VF MD 6–12 dB with field loss not within central 10°

  • Advanced glaucoma: VF MD > 12 dB with potential central involvement

  • Unstable: IOP not within target or fluctuating > 3 mmHg; disc changes/haemorrhage; VF changes; intolerance to treatment

  • Acute: angle-closure, uveitis, neovascular, or secondary glaucoma with high IOP (e.g., PXF/PDS-induced)

OHT asymmetry/asymmetric OHT and NICE management framework (OHT/Asymmetric OHT vs LTG vs normal)

  • Asymmetric OHT (funny disc) and LTG vs Normal:

    • Management strategies depend on risk assessment

    • Low risk: A–D management by Optometrist

    • Low risk with risk factor: Co-management

    • Low risk with E category (e.g., additional risk factors): Co-management

    • High risk: Co-management (referral and closer follow-up)

  • The pathway emphasizes collaboration between ophthalmologists and optometrists for timely diagnosis and management of glaucoma and suspects